| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,696 |
11,531 |
$1.91M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,916 |
7,139 |
$753K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,750 |
4,727 |
$663K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,125 |
2,555 |
$440K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,788 |
4,371 |
$275K |
| 71045 |
Radiologic examination, chest; single view |
1,586 |
1,263 |
$204K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,803 |
1,553 |
$186K |
| 80053 |
Comprehensive metabolic panel |
14,612 |
12,001 |
$94K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
705 |
631 |
$73K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
663 |
593 |
$69K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
11,766 |
9,598 |
$60K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
381 |
331 |
$59K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,556 |
1,107 |
$53K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
137 |
100 |
$48K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
651 |
526 |
$39K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,089 |
833 |
$31K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,452 |
2,225 |
$30K |
| 36415 |
Collection of venous blood by venipuncture |
11,566 |
9,296 |
$28K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
226 |
218 |
$26K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,562 |
1,214 |
$24K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
716 |
589 |
$16K |
| 85027 |
|
2,541 |
2,157 |
$13K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
166 |
157 |
$12K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
494 |
426 |
$12K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
96 |
63 |
$11K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
480 |
413 |
$11K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
95 |
94 |
$11K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
166 |
152 |
$10K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
245 |
203 |
$10K |
| 70450 |
Computed tomography, head or brain; without contrast material |
109 |
81 |
$10K |
| 71046 |
Radiologic examination, chest; 2 views |
56 |
54 |
$9K |
| 11719 |
|
771 |
331 |
$9K |
| 80061 |
Lipid panel |
1,186 |
1,064 |
$9K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
40 |
37 |
$7K |
| 81001 |
|
3,028 |
2,384 |
$6K |
| 83735 |
|
847 |
683 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
47 |
47 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,035 |
821 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
868 |
783 |
$5K |
| 83615 |
|
216 |
149 |
$5K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
97 |
81 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
180 |
172 |
$4K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
97 |
81 |
$4K |
| 84145 |
|
257 |
191 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
195 |
169 |
$3K |
| J7050 |
Infusion, normal saline solution, 250 cc |
334 |
261 |
$3K |
| 20610 |
|
19 |
12 |
$3K |
| 87088 |
|
453 |
383 |
$3K |
| 84439 |
|
423 |
393 |
$3K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
130 |
106 |
$3K |
| 84484 |
|
172 |
127 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
26 |
25 |
$2K |
| 83690 |
|
487 |
406 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
12 |
$2K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
127 |
105 |
$2K |
| 87631 |
|
25 |
15 |
$2K |
| 83605 |
|
228 |
173 |
$1K |
| 82607 |
|
143 |
130 |
$1K |
| 81003 |
|
783 |
485 |
$1K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
34 |
27 |
$1K |
| 80306 |
|
116 |
92 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
66 |
58 |
$918.14 |
| 86140 |
|
237 |
194 |
$796.45 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
59 |
29 |
$778.69 |
| 82150 |
|
169 |
132 |
$724.84 |
| 36416 |
|
86 |
70 |
$669.26 |
| 81015 |
|
147 |
123 |
$559.07 |
| 73560 |
|
15 |
12 |
$528.50 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
49 |
40 |
$528.04 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
100 |
82 |
$506.19 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
17 |
13 |
$354.96 |
| 82550 |
|
66 |
52 |
$300.88 |
| 84481 |
|
28 |
27 |
$266.74 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
117 |
112 |
$244.80 |
| 85018 |
|
60 |
52 |
$124.77 |
| 82746 |
|
13 |
12 |
$117.60 |
| 87040 |
|
19 |
16 |
$104.96 |
| 85610 |
|
26 |
25 |
$96.05 |
| 90686 |
|
195 |
184 |
$91.34 |
| 82947 |
|
26 |
25 |
$77.42 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
17 |
13 |
$74.57 |
| 84703 |
|
12 |
12 |
$69.94 |
| 85730 |
|
16 |
15 |
$45.92 |
| 82553 |
|
18 |
14 |
$32.77 |
| 81025 |
|
16 |
12 |
$25.05 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
907 |
731 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
122 |
101 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
105 |
61 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
17 |
14 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
16 |
12 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
18 |
17 |
$0.00 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
429 |
357 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15 |
12 |
$0.00 |